NUVL
Nuvalent, Inc.
NASDAQ · Healthcare · Biotechnology · US
$123.96
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 8.34x
- Price / sales
- —
- Price / cash flow
- -31.31x
Enterprise value
- Enterprise value
- $8.5B
- EV / sales
- —
- EV / EBITDA
- -25.44x
- EV / EBIT
- -19.38x
- Market cap
- $9.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026